JK, C., A, B., MK, T., BJ, H., AMC, Y., M, P., . . . SG, G. (2023). Antithrombotic therapies in Canadian atrial fibrillation patients with concomitant coronary artery disease: Insights from the CONNECT AF + PCI-II program. Journal of cardiology, 82(2), 153. https://doi.org/10.1016/j.jjcc.2023.03.004
Chicago Style (17th ed.) CitationJK, Chow, et al. "Antithrombotic Therapies in Canadian Atrial Fibrillation Patients with Concomitant Coronary Artery Disease: Insights from the CONNECT AF + PCI-II Program." Journal of Cardiology 82, no. 2 (2023): 153. https://doi.org/10.1016/j.jjcc.2023.03.004.
MLA (9th ed.) CitationJK, Chow, et al. "Antithrombotic Therapies in Canadian Atrial Fibrillation Patients with Concomitant Coronary Artery Disease: Insights from the CONNECT AF + PCI-II Program." Journal of Cardiology, vol. 82, no. 2, 2023, p. 153, https://doi.org/10.1016/j.jjcc.2023.03.004.